These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16045197)

  • 1. [Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes].
    Yasui M; Kato A; Kanemasa T; Murata S; Nishitomi K; Koike K; Tai N; Shinohara S; Tokomura M; Horiuchi M; Abe K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):143-51. PubMed ID: 16045197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
    Griebel G; Perrault G; Sanger DJ
    J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.
    Perrault G; Morel E; Sanger DJ; Zivkovic B
    Eur J Pharmacol; 1990 Oct; 187(3):487-94. PubMed ID: 1981555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative affinity of quazepam for type-1 benzodiazepine receptors in brain.
    Wamsley JK; Hunt MA
    J Clin Psychiatry; 1991 Sep; 52 Suppl():15-20. PubMed ID: 1680119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K+ channel TASK-1 knockout mice show enhanced sensitivities to ataxic and hypnotic effects of GABA(A) receptor ligands.
    Linden AM; Aller MI; Leppä E; Rosenberg PH; Wisden W; Korpi ER
    J Pharmacol Exp Ther; 2008 Oct; 327(1):277-86. PubMed ID: 18660435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of short- and long-acting benzodiazepine-receptor agonists with different receptor selectivity on motor coordination and muscle relaxation following thiopental-induced anesthesia in mice.
    Tanaka M; Suemaru K; Watanabe S; Cui R; Li B; Araki H
    J Pharmacol Sci; 2008 Jul; 107(3):277-84. PubMed ID: 18603831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological studies of a new sleep-inducer, 1H-1,2,4-triazolyl benzophenone derivatives (450191-S) (I). Behavioral analysis].
    Yamamoto K; Hirose K; Matsushita A; Yoshimura K; Sawada T; Eigyo M; Jyoyama H; Fujita A; Matsubara K; Tsukinoki Y
    Nihon Yakurigaku Zasshi; 1984 Jul; 84(1):109-54. PubMed ID: 6149174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation.
    Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER
    Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone.
    Byrnes JJ; Greenblatt DJ; Miller LG
    Brain Res Bull; 1992 Dec; 29(6):905-8. PubMed ID: 1361878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of anxiolytic and sedative drugs: pharmacological specificity.
    Sanger DJ
    Psychopharmacol Ser; 1988; 4():73-84. PubMed ID: 2899319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
    Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
    Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem.
    Sanger DJ; Morel E; Perrault G
    Eur J Pharmacol; 1996 Oct; 313(1-2):35-42. PubMed ID: 8905326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of the hypnotic zolpidem in vivo.
    Crestani F; Martin JR; Möhler H; Rudolph U
    Br J Pharmacol; 2000 Dec; 131(7):1251-4. PubMed ID: 11090095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anxiolytic-like effects of some short-acting benzodiazepine hypnotics in mice.
    Nishino T; Takeuchi T; Takechi K; Kamei C
    J Pharmacol Sci; 2008 Jul; 107(3):349-54. PubMed ID: 18603828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.